Das J - Search Results

1

Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.

Das J, Floyd DM, Kimball SD, Duff KJ, Lago MW, Krapcho J, White RE, Ridgewell RE, Obermeier MT, Moreland S, et al. Das J, et al. J Med Chem. 1992 Jul 10;35(14):2610-7. doi: 10.1021/jm00092a011. J Med Chem. 1992. PMID: 1635059

2

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

Kimball SD, Floyd DM, Das J, Hunt JT, Krapcho J, Rovnyak G, Duff KJ, Lee VG, Moquin RV, Turk CF, et al. Kimball SD, et al. Among authors: das j. J Med Chem. 1992 Feb 21;35(4):780-93. doi: 10.1021/jm00082a020. J Med Chem. 1992. PMID: 1311765

3

Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.

Floyd DM, Kimball SD, Krapcho J, Das J, Turk CF, Moquin RV, Lago MW, Duff KJ, Lee VG, White RE, et al. Floyd DM, et al. Among authors: das j. J Med Chem. 1992 Feb 21;35(4):756-72. doi: 10.1021/jm00082a018. J Med Chem. 1992. PMID: 1542102

4

Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.

Das J, Floyd DM, Kimball SD, Duff KJ, Vu TC, Lago MW, Moquin RV, Lee VG, Gougoutas JZ, Malley MF, et al. Das J, et al. J Med Chem. 1992 Feb 21;35(4):773-80. doi: 10.1021/jm00082a019. J Med Chem. 1992. PMID: 1542103

5

Thrombin active site inhibitors.

Das J, Kimball SD. Das J, et al. Bioorg Med Chem. 1995 Aug;3(8):999-1007. doi: 10.1016/0968-0896(95)00104-o. Bioorg Med Chem. 1995. PMID: 7582987 Review.

6

1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.

Kimball SD, Hunt JT, Barrish JC, Das J, Floyd DM, Lago MW, Lee VG, Spergel SH, Moreland S, Hedberg SA, et al. Kimball SD, et al. Among authors: das j. Bioorg Med Chem. 1993 Oct;1(4):285-307. doi: 10.1016/s0968-0896(00)82134-3. Bioorg Med Chem. 1993. PMID: 8081860

7

Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole.

Humphreys WG, Obermeier MT, Chong S, Kimball SD, Das J, Chen P, Moquin R, Han WC, Gedamke R, White RE, Morrison RA. Humphreys WG, et al. Among authors: das j. Xenobiotica. 2003 Jan;33(1):93-106. doi: 10.1080/0049825021000012592. Xenobiotica. 2003. PMID: 12519697

8

Imidazoquinoxaline Src-family kinase p56Lck inhibitors: SAR, QSAR, and the discovery of (S)-N-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity.

Chen P, Doweyko AM, Norris D, Gu HH, Spergel SH, Das J, Moquin RV, Lin J, Wityak J, Iwanowicz EJ, McIntyre KW, Shuster DJ, Behnia K, Chong S, de Fex H, Pang S, Pitt S, Shen DR, Thrall S, Stanley P, Kocy OR, Witmer MR, Kanner SB, Schieven GL, Barrish JC. Chen P, et al. Among authors: das j. J Med Chem. 2004 Aug 26;47(18):4517-29. doi: 10.1021/jm030217e. J Med Chem. 2004. PMID: 15317463

9

7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza omega-chain analogues.

Nakane M, Reid JA, Han WC, Das J, Truc VC, Haslanger MF, Garber D, Harris DN, Hedberg A, Ogletree ML, et al. Nakane M, et al. Among authors: das j. J Med Chem. 1990 Sep;33(9):2465-76. doi: 10.1021/jm00171a021. J Med Chem. 1990. PMID: 2391688

10

Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.

Das J, Vu T, Harris DN, Ogletree ML. Das J, et al. J Med Chem. 1988 May;31(5):930-5. doi: 10.1021/jm00400a007. J Med Chem. 1988. PMID: 2966247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,907 results

Search Page